Oruka Therapeutics (ORKA) Interest Coverage Ratio (2010 - 2024)
Oruka Therapeutics (ORKA) posted quarterly Interest Coverage Ratio of 0.2 for Q2 2024, up 99.54% year-over-year from 0.1 in Q3 2023, and up 59.16% quarter-over-quarter from 0.5 in Q1 2024.
Oruka Therapeutics (ORKA) Interest Coverage Ratio (2010 - 2024) Analysis & Trends
Oruka Therapeutics' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 0.2 for Q2 2024.
- In Q2 2024, Interest Coverage Ratio rose 99.54% year-over-year to 0.2; the TTM figure through Jun 2024 stood at 0.45 (up 99.74% YoY), while the FY2023 annual figure was 0.13, up 32.58% from the prior year.
- Interest Coverage Ratio for Q2 2024 stood at 0.2, up from 0.5 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.2 in Q2 2024, with the low at 995.0 in Q3 2020.
- The 5-year median for Interest Coverage Ratio is 52.4 (2020), against an average of 129.92.
- The sharpest annual moves came in 2020 and 2024: Interest Coverage Ratio tumbled 1096.87% in 2020, then soared 99.54% in 2024.
- Oruka Therapeutics' Interest Coverage Ratio stood at 68.35 in 2020, then decreased by 25.92% to 86.06 in 2021, then soared by 54.38% to 39.26 in 2022, then sank by 55.76% to 61.15 in 2023, then surged by 99.67% to 0.2 in 2024.
- Business Quant data shows ORKA's Interest Coverage Ratio at 0.2 in Q2 2024, 0.5 in Q1 2024, and 61.15 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Oruka Therapeutics | 6.98 Bn | 5.25 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -0.20 |
| Mar 31, 2024 | -0.50 |
| Dec 31, 2023 | -61.15 |
| Sep 30, 2023 | -5.70 |
| Jun 30, 2023 | -43.84 |
| Mar 31, 2023 | -54.42 |
| Sep 30, 2022 | -39.26 |
| Jun 30, 2022 | -6.35 |
| Mar 31, 2022 | -102.41 |
| Dec 31, 2021 | -86.06 |
| Sep 30, 2021 | -7.81 |
| Jun 30, 2021 | -45.63 |
| Mar 31, 2021 | -586.00 |
| Dec 31, 2020 | -68.35 |
| Sep 30, 2020 | -995.00 |
| Jun 30, 2020 | -52.40 |
| Mar 31, 2020 | -53.60 |
| Dec 31, 2019 | -18.26 |
| Sep 30, 2019 | -83.13 |
| Jun 30, 2019 | -39.68 |